Coming soon: LGBTQIA+ Affirming Provider Designation toolkits
Dec. 2023Important Notices
In the coming weeks, we will send the LGBTQIA+ Affirming Provider Designation toolkits to providers who have earned the designation to date. These kits include a provider welcome letter, postcard, badge reel, lapel pin, table tent, and talking points for office staff. Please note that this shipment requires a signature for delivery.
Interested in earning the designation?
We encourage all providers to earn the LGBTQIA+ Affirming Provider Designation. To get started, complete these three modules:
Interested in earning the designation?
We encourage all providers to earn the LGBTQIA+ Affirming Provider Designation. To get started, complete these three modules:
Recent Announcements
Voluntary nationwide recall: Cetirizine (Unique – July)
Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is recalling four lots (GY825029, GY825030, GY825031, GY825032) of Cetirizine Hydrochloride Tablets USP 5 mg. Cetirizine is used for the relief of allergy symptoms, including itchy, red, watery eyes and itchy skin.Jul. 2026Pharmacy Updates
August 2026 UPMC for You and UPMC Community HealthChoices Formulary Updates
Effective Aug. 15, 2026, UPMC for You and UPMC Community HealthChoices are updating their formularies.Jul. 2026Pharmacy Updates
Give feedback on your experience with UPMC Health Plan
You may be invited to participate in a 2026 Press Ganey provider satisfaction survey, which will begin next month. This survey will be given to a random sampling of in-network primary care providers.Jul. 2026Important Notices